Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Hematopoietic and Lymphatic System Neoplasm 3Neoplasms 2Malignant Solid Neoplasm 2Lung Neoplasms 2Breast Neoplasms 2Spondylitis, Ankylosing 1Smoking Cessation 1Sarcoma 1Pyloric Stenosis, Hypertrophic 1Psoriasis 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Oropharyngeal Neoplasms 1Obesity 1Mouth Neoplasms 1Mental Disorders 1Melanoma 1Malignant Female Reproductive System Neoplasm 1Lupus Erythematosus, Systemic 1Localized Head and Neck Carcinoma 1Laryngeal Neoplasms 1Inflammatory Bowel Diseases 1Hypopharyngeal Neoplasms 1Head and Neck Neoplasms 1Depressive Disorder 1Depression 1Crohn Disease 1Colorectal Neoplasms 1Colitis, Ulcerative 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Specimen Handling 1Psilocybin 1Interviews as Topic 1Counseling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Depressive Disorder × Interviews as Topic × 30 days × Clear all
NCT07216404 2026-05-14

Psilocybin-Assisted Therapy for the Treatment of Major Depressive Disorder in Patients With Non-Small Cell Lung Cancer

Ohio State University Comprehensive Cancer Center

Phase 2 Recruiting
10 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Depressive Disorder

Data powered by HemOnc (CC BY 4.0) Colophon âš¡